Table 3.
Hazard ratio (95% CI) | ||||
---|---|---|---|---|
Model 1 | P value | Model 2 | P value | |
Nephropathy | ||||
VAI (ref: lower) | – | – | ||
Middle | 1.222 (0.976–1.531) | 0.080 | 1.098 (0.873–1.382) | 0.425 |
Upper | 1.571 (1.251–1.973) | < 0.001 | 1.338 (1.033–1.735) | 0.028 |
CVAI (ref: lower) | – | – | ||
Middle | 1.136 (0.851–1.516) | 0.387 | 0.989 (0.737–1.325) | 0.938 |
Upper | 1.690 (1.293–2.208) | < 0.001 | 1.317 (0.975–1.780) | 0.073 |
Retinopathy | ||||
VAI (ref: lower) | – | – | ||
Middle | 1.025 (0.587–1.790) | 0.930 | 0.765 (0.431–1.361) | 0.363 |
Upper | 1.536 (0.915–2.578) | 0.104 | 0.696 (0.354–1.367) | 0.292 |
CVAI (ref: lower) | – | – | ||
Middle | 2.198 (1.119–4.317) | 0.022 | 1.369 (0.688–2.722) | 0.371 |
Upper | 2.335 (1.188–4.589) | 0.014 | 1.134 (0.518–2.484) | 0.754 |
Model 1: adjusted for age and sex
Model 2: age, sex, BMI group, education level, smoking status, drinking status, physical activity, hypertension, dyslipidaemia, fasting glucose and use of antidiabetic medication;
VAI visceral adiposity index, CVAI Chinese visceral adiposity index